Jazz Pharmaceuticals plc - FORM 10-Q - EX-10.1B - AMENDMENT NO. 2 TO PHARMACY MASTER SERVICES AGREEMENT - August 3, 2021

Attached files

file filename
10-Q - 10-Q - Jazz Pharmaceuticals plcjazz-20210630.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcjazzq22021ex321.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq22021ex312.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcjazzq22021ex311.htm
EX-10.11 - AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - Jazz Pharmaceuticals plcjazzq22021ex1011.htm
EX-10.10D - REPLACEMENT RSU AGREEMENT - GW 2020 LTIP - Jazz Pharmaceuticals plcjazzq22021ex1010d.htm
EX-10.10C - REPLACEMENT OPTION AGREEMENT - GW 2020 LTIP - Jazz Pharmaceuticals plcjazzq22021ex1010c.htm
EX-10.10B - RSU AGREEMENT - GW 2020 LTIP - Jazz Pharmaceuticals plcjazzq22021ex1010b.htm
EX-10.9 - NON-US RSU NOTICE & AGREEMENT - 2011 EIP - Jazz Pharmaceuticals plcjazzq22021ex109.htm
EX-10.8 - US RSU NOTICE & AGREEMENT - 2011 EIP - Jazz Pharmaceuticals plcjazzq22021ex108.htm
EX-10.7 - NON-US PERFORMANCE RSU NOTICE & AGREEMENT - 2011 EIP - Jazz Pharmaceuticals plcjazzq22021ex107.htm
EX-10.6 - US PERFORMANCE RSU NOTICE & AGREEMENT - 2011 EIP - Jazz Pharmaceuticals plcjazzq22021ex106.htm
EX-10.5 - PARTICIPATION AGREEMENT - Jazz Pharmaceuticals plcjazzq22021ex105.htm
EX-10.4 - SERVICE AGREEMENT - Jazz Pharmaceuticals plcjazzq22021ex104.htm
EX-10.2 - AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT - Jazz Pharmaceuticals plcjazzq22021ex102.htm
EX-10.1A - AMENDMENT NO. 1 TO PHARMACY MASTER SERVICES AGREEMENT - Jazz Pharmaceuticals plcjazzq22021ex101a.htm
EX-4.5C - FIRST SUPPLEMENTAL INDENTURE - Jazz Pharmaceuticals plcjazzq22021ex45c.htm



Exhibit 10.1B


AMENDMENT #2

TO PHARMACY SERVICES MASTER SERVICES AGREEMENT
This Amendment #2 to Pharmacy Master Services Agreement (“Amendment”), effective as of the last date signed below (the “Effective Date”), is made pursuant to the terms of the Pharmacy Services Master Services Agreement (“Agreement”), effective as of July 1, 2020 between Jazz Pharmaceuticals, Inc. (“Jazz Pharmaceuticals”) and Express Scripts Specialty Distribution Services, Inc. (“ESSDS”) (individually, “Party” and collectively, “Parties”), the terms of which are incorporated herein by reference.
Whereas, ESSDS intends to relocate the fulfillment operations of the Certified Pharmacy.

Now therefore, in consideration of the above recital, which is incorporated by this reference, the mutual promises and covenants set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:


1.    Exhibit B hereby deleted and replaced in its’ entirety with Exhibit B below.
2.    In the event of any conflict or inconsistency between the terms and provisions of the Agreement and the terms and provisions of this Amendment, the terms and provisions of this Amendment will govern and prevail. Except as expressly provided in this Amendment, this Amendment does not in any way change, modify or delete the provisions of the Agreement (or the Parties’ rights, remedies or obligations thereunder), and all such provisions shall remain in full force and effect. On and after the Amendment Effective Date, each reference in the Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference to the Agreement in any other agreements, documents or instruments executed and delivered pursuant to the Agreement, shall mean and be a reference to the Agreement, as amended by this Amendment.










1




IN WITNESS WHEREOF, by signature of their respective duly authorized representatives below, the Parties have agreed to this Amendment as of the Effective Date.



EXPRESS SCRIPTS SPECIALTY DISTRIBUTIONS SERVICES, INC. JAZZ PHARMACEUTICALS, INC.
By: Joshua B Parker
By: /s/ Debra Feldman
Signature: /s/ Joshua B. Parker
Signature: Debra Feldman
Title: VP
Title: VP, Pharmacovigilance
Date: 7/13/2021 | 3:52 PM CDT
Date: 19-Jul-2021
              RPM for JLD 7.13.21

2



Exhibit B

ESSDS LOCATIONS


Express Scripts Building 3 4600 North Hanley Rd. Suite B St. Louis, MO 63134

Express Scripts Building 6 4700 North Hanley Rd. St. Louis, MO 63134
3

Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports